Michael Goldstein - Teladoc Independent Director
| 4LL Stock | EUR 9.02 0.34 3.92% |
Director
Mr. Michael S. Goldstein, CPA is an Independent Director of the TELADOC, INC.since February 2015. Mr. Goldstein was employed by Ernst Young from 1963 to 1979, including six years as an audit partner. Mr. Goldstein served as Chairman of Toys R Us, Inc. from 1998 to 2001, Chief Executive Officer from 1999 to 2000, Vice Chairman and Chief Executive Officer from 1994 to 1998 and Chief Financial Officer from 1983 to 1994. Mr. Goldstein was a director of BioScrip, Inc. since 2015 and is chairman of the audit committee and a member of the governance, compliance and nominating committee and corporate strategy committee. Mr. Goldman was also a director and chairman of the audit committee of Pacific Sunwear of California, Inc. from 2004 to 2016. Mr. Goldstein is on the boards of two non public companies RiHappy, the largest Brazilian toy retailer and Bank LeumiUSA. He is also a Global Senior Advisor of Jefferies, Inc. Mr. Goldstein is a board member and former Chairman of the Board of the 92nd Street Y and serves on the board of Rosies Theater Kids. He is Chairman of the Northside Center for Child Development. Mr. Goldstein served on the boards of the following public companies within the last five years Charming Shoppes, Inc., from 2008 to 2012 4 Kids Entertainment, Inc. from 2002 to 2012 and Medco Health Solutions, Inc. from 2005 to 2012. since 2015.
| Age | 77 |
| Tenure | 9 years |
| Phone | 203 635 2002 |
| Web | https://www.teladochealth.com |
Michael Goldstein Latest Insider Activity
Tracking and analyzing the buying and selling activities of Michael Goldstein against Teladoc stock is an integral part of due diligence when investing in Teladoc. Michael Goldstein insider activity provides valuable insight into whether Teladoc is net buyers or sellers over its current business cycle. Note, Teladoc insiders must abide by specific rules, including filing SEC forms every time they buy or sell Teladoc'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Michael Goldstein over six months ago Disposition of tradable shares by Michael Goldstein of Tucows subject to Rule 16b-3 |
Teladoc Management Efficiency
The company has return on total asset (ROA) of (0.0129) % which means that it has lost $0.0129 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.4885) %, meaning that it generated substantial loss on money invested by shareholders. Teladoc's management efficiency ratios could be used to measure how well Teladoc manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | DIRECTOR Age | ||
| Kimberly Popovits | 10X GENOMICS DL | 60 | |
Management Performance
| Return On Equity | -1.49 | |||
| Return On Asset | -0.0129 |
Teladoc Leadership Team
Elected by the shareholders, the Teladoc's board of directors comprises two types of representatives: Teladoc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Teladoc. The board's role is to monitor Teladoc's management team and ensure that shareholders' interests are well served. Teladoc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Teladoc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Goldstein, Independent Director | ||
| Mike Waters, Chief Officer | ||
| Andrew Turitz, Senior Vice President of Business Development | ||
| Catherine Jacobson, Independent Director | ||
| Sandra Fenwick, Director | ||
| Michelle Bucaria, Chief Human Resource Officer | ||
| Christopher Bischoff, Director | ||
| David Shedlarz, Independent Director | ||
| William Frist, Independent Director | ||
| Mala Murthy, Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Controller | ||
| Mark Smith, Independent Director | ||
| David Snow, Independent Chairman of the Board | ||
| David Sides, Chief Operating Officer | ||
| Richard Napolitano, Chief VP | ||
| Thomas McKinley, Independent Director | ||
| Christopher Caridi, Senior Vice President Chief Accounting Officer, Controller | ||
| Karen Daniel, Director | ||
| Lewis Levy, Chief Medical Officer | ||
| Claus Jensen, Chief Officer | ||
| Adam Vandervoort, Chief Legal Officer and Secretary | ||
| Gabriel Cappucci, Senior Vice President Chief Accounting Officer, Controller | ||
| Kenneth Paulus, Independent Director | ||
| Stephanie Verstraete, Chief Marketing Officer | ||
| George Brooks, CoFounder | ||
| Hemant Taneja, Director | ||
| Glen Tullman, Director | ||
| Helen Darling, Independent Director | ||
| CPA CFA, VP Relations | ||
| Jason Gorevic, Chief Executive Officer, Director | ||
| Courtney McLeod, Director Communication |
Teladoc Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Teladoc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.49 | |||
| Return On Asset | -0.0129 | |||
| Operating Margin | (0.09) % | |||
| Current Valuation | 5.01 B | |||
| Shares Outstanding | 162.84 M | |||
| Shares Owned By Insiders | 0.96 % | |||
| Shares Owned By Institutions | 82.07 % | |||
| Price To Book | 0.75 X | |||
| Price To Sales | 1.77 X | |||
| Revenue | 2.41 B |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Teladoc Stock
When determining whether Teladoc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teladoc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teladoc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teladoc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Teladoc Stock please use our How to Invest in Teladoc guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.